AN UNBIASED VIEW OF PENTOBARBITAL SODIUM IN HUMANS

Contraindicated (one)pentobarbital will decrease the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers may lead to lessened serum concentrations and lack of antimalarial efficacyProblems over the effectiveness of multi-drug lethal injections also